[144] Veeco Instruments Inc SEC Filing

Rhea-AI Filing Summary

Veeco Instruments Inc. (VECO) filed a Form 144 reporting a proposed sale of 25,000 shares of common stock through Wells Fargo Clearing Services with an aggregate market value of $624,493.00. The filing lists the approximate outstanding shares as 60,161,823 and an intended sale date of 09/09/2025 on Nasdaq.

The shares to be sold were acquired in 2024 as grants: 7,138 shares on 03/13/2024, 6,787 on 03/12/2024 and 11,075 on 03/18/2024. The filer indicates no sales in the past three months and certifies no undisclosed material adverse information. This is a routine Rule 144 notice describing a proposed sale by a person whose holdings were obtained via issuer grants.

Positive

• Transparent disclosure of the proposed sale under Rule 144 including broker, quantity, value, and intended sale date
• Origin of shares specified as issuer grants on 03/12/2024, 03/13/2024, and 03/18/2024, clarifying acquisition basis
• No sales in prior three months reported, which simplifies volume aggregation analysis under Rule 144

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 filing disclosing a small proposed sale from issuer grants; procedural compliance appears met.

The filing documents a notice under Rule 144 for 25,000 common shares valued at $624,493, to be executed through Wells Fargo on Nasdaq. Acquisition records show the shares were issued as grants in March 2024, which is relevant for holding-period and volume limitations under Rule 144. The filer affirms no undisclosed material adverse information and reports no sales in the prior three months, consistent with a compliant disclosure. No regulatory flags or complex financing arrangements are disclosed.

Equity Research Associate

TL;DR: The proposed sale is small relative to total shares outstanding and likely has limited market impact.

At 25,000 shares versus 60,161,823 outstanding, the proposed disposal represents roughly 0.04% of the outstanding float, indicating minimal dilution or market impact if executed. The shares originate from issuer grants dated March 2024, not open-market purchases, which clarifies the provenance but does not provide intent beyond the declared sale. The filing contains standard attestations and lacks additional financial detail.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Wells Fargo Clearing Services 1 North Jefferson Avenue St. Louis MO 63103	25000	624493.00	60161823	09/09/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/13/2024	Grants	Issuer			7138	03/13/2024	N/A
common	03/12/2024	Grants	Issuer			6787	03/12/2024	N/A
common	03/18/2024	Grants	Issuer			11075	03/18/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does VECO's Form 144 report about the proposed sale?

The filing reports a proposed sale of 25,000 common shares via Wells Fargo with aggregate market value of $624,493.00, to be sold on 09/09/2025 on Nasdaq.

How were the shares being sold by the VECO filer acquired?

The shares were acquired as grants from the issuer on 03/12/2024 (6,787), 03/13/2024 (7,138), and 03/18/2024 (11,075).

What portion of Veeco's outstanding shares does this proposed sale represent?

The filing lists 60,161,823 shares outstanding; the proposed 25,000 shares equal approximately 0.04% of that total.

Does the filer report any sales of VECO securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filer claim any undisclosed material information about VECO?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.